{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:53:46Z","timestamp":1777874026654,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013816","name":"Generalitat de Catalunya Departament d&apos;Innovacio Universitats I Empresa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013816","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.biopha.2026.119184","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:19:47Z","timestamp":1773163187000},"page":"119184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8926-2952","authenticated-orcid":false,"given":"Ferran","family":"Medina-Jover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Figueras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7761-3695","authenticated-orcid":false,"given":"N\u00faria","family":"Gendrau-Sanclemente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Racionero-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9814-1025","authenticated-orcid":false,"given":"Meritxell","family":"Sociats-Font","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Lahiguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau","family":"Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Tormo-Fabios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2494-0964","authenticated-orcid":false,"given":"Roderic","family":"Esp\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4823-6613","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Pardo-Cea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Mendez-Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edurne","family":"Berra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep Maria","family":"Piulats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Ayt\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3108-0571","authenticated-orcid":false,"given":"Adri\u00e0","family":"Bernat-Peguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miquel Angel","family":"Pujana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Carlos","family":"Perales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9918-6751","authenticated-orcid":false,"given":"Francesc","family":"Vi\u00f1als","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119184_bib1","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/bies.201400102","article-title":"ATP puts the brake on DNA double-strand break repair: a new study shows that ATP switches the Mre11-Rad50-Nbs1 repair factor between signaling and processing of DNA ends Prospects & Overviews K.-P. Hopfner","volume":"36","author":"Hopfner","year":"2014","journal-title":"BioEssays"},{"key":"10.1016\/j.biopha.2026.119184_bib2","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fonc.2019.01388","article-title":"Harnessing DNA double-strand break repair for cancer treatment","volume":"9","author":"Trenner","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119184_bib3","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2026.119184_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: Basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119184_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.16.00031","article-title":"Homologous Recombination Deficiency in Breast Cancer: A Clinical Review","author":"den Brok","year":"2017","journal-title":"JCO Precis Oncol."},{"key":"10.1016\/j.biopha.2026.119184_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41391-019-0153-2","article-title":"Role of the DNA damage response in prostate cancer formation, progression and treatment","volume":"23","author":"Zhang","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.biopha.2026.119184_bib7","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0006-291X(80)80009-X","article-title":"Inhibitors of poly(adenosine diphosphate ribose) polymerase induce sister chromatid exchanges","volume":"97","author":"Oikawa","year":"1980","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2026.119184_bib8","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.1073\/pnas.94.14.7303","article-title":"Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells","volume":"94","author":"M\u00e9nissier De Murcia","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119184_bib9","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1158\/2159-8290.CD-13-0891","article-title":"PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination\u2013mediated DNA repair","volume":"4","author":"Hu","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2026.119184_bib10","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1093\/nar\/gkz120","article-title":"Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins","volume":"47","author":"Alemasova","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2026.119184_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ygyno.2012.03.006","article-title":"BRCA1\/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer","volume":"125","author":"Dann","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2026.119184_bib12","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumors with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119184_bib13","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119184_bib14","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1200\/JCO.2008.16.0812","article-title":"A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair","volume":"26","author":"Ashworth","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119184_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11523-016-0435-8","article-title":"An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib","volume":"11","author":"Mateo","year":"2016","journal-title":"Target Oncol."},{"key":"10.1016\/j.biopha.2026.119184_bib16","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdz192","article-title":"A decade of clinical development of PARP inhibitors in perspective","volume":"30","author":"Mateo","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2026.119184_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa1802905","article-title":"Talazoparib in patients with advanced breast cancer and a germline BRCA mutation","volume":"379","author":"Litton","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119184_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119184_bib19","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for metastatic castration-resistant prostate cancer","volume":"382","author":"de Bono","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2026.119184_bib20","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1200\/JCO.20.01035","article-title":"Rucaparib in men with metastatic castration-resistant prostate cancer harboring a BRCA1 or BRCA2 gene alteration","volume":"38","author":"Abida","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119184_bib21","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911217","article-title":"Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors","volume":"12","author":"Lahiguera","year":"2020","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.biopha.2026.119184_bib22","doi-asserted-by":"crossref","first-page":"37223","DOI":"10.1074\/jbc.M103069200","article-title":"Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase","volume":"276","author":"Korotchkina","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119184_bib23","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1021\/bi700083z","article-title":"Phosphorylation of serine 264 impedes active site accessibility in the E1 component of the human pyruvate dehydrogenase multienzyme complex","volume":"46","author":"Seifert","year":"2007","journal-title":"Biochemistry"},{"issue":"1 6","key":"10.1016\/j.biopha.2026.119184_bib24","first-page":"1","article-title":"Hypoxic repression of pyruvate dehydrogenase activity is necessary for metabolic reprogramming and growth of model tumors","volume":"6","author":"Golias","year":"2016","journal-title":"Sci. Rep. 2016"},{"key":"10.1016\/j.biopha.2026.119184_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119184_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.biopha.2026.119184_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc4465","article-title":"Loss of TGF\u03b2 signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.biopha.2026.119184_bib28","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2026.119184_bib29","article-title":"A R T I C L E S PGC-1\u03b1-Responsive Genes Involved in Oxidative Phosphorylation Are Coordinately Downregulated in Human Diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet. VOLUME"},{"key":"10.1016\/j.biopha.2026.119184_bib30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/bioinformatics\/btn615","article-title":"AmiGO: online access to ontology and annotation data","volume":"25","author":"Carbon","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2026.119184_bib31","article-title":"The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins","volume":"2016","author":"Rouillard","year":"2016","journal-title":"Database (Oxf. )"},{"key":"10.1016\/j.biopha.2026.119184_bib32","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2026.119184_bib33","doi-asserted-by":"crossref","first-page":"W175","DOI":"10.1093\/nar\/gkac199","article-title":"ChIP-Atlas 2021 update: a data-mining suite for exploring epigenomic landscapes by fully integrating ChIP-seq, ATAC-seq and Bisulfite-seq data","volume":"50","author":"Zou","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2026.119184_bib34","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/0008-5472.CAN-16-1272","article-title":"CRISPR\/Cas9-mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high-grade serous carcinoma","volume":"76","author":"Walton","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2026.119184_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1158\/1078-0432.CCR-09-2434","article-title":"A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors","volume":"16","author":"Evers","year":"2010","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.biopha.2026.119184_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-5793(01)02159-7","article-title":"HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1\u03b1 degradation","volume":"491","author":"Berra","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2026.119184_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119184_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/bj3580069","article-title":"Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites","volume":"358","author":"Kolobova","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2026.119184_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molcel.2020.09.018","article-title":"Phosphorylation of PDHA by AMPK Drives TCA Cycle to Promote Cancer Metastasis","volume":"80","author":"Cai","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2026.119184_bib40","first-page":"1","article-title":"Dynamic regulation of mitochondrial pyruvate metabolism is necessary for orthotopic pancreatic tumor growth","volume":"9","author":"Ruiz","year":"2021","journal-title":"Cancer Metab."},{"key":"10.1016\/j.biopha.2026.119184_bib41","doi-asserted-by":"crossref","first-page":"W175","DOI":"10.1093\/nar\/gkac199","article-title":"ChIP-Atlas 2021 update: a data-mining suite for exploring epigenomic landscapes by fully integrating ChIP-seq, ATAC-seq and Bisulfite-seq data","volume":"50","author":"Zou","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2026.119184_bib42","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119184_bib43","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s12272-011-1021-3","article-title":"A novel approach to cancer therapy using PX-478 as a HIF-1\u03b1 inhibitor","volume":"34","author":"Lee","year":"2011","journal-title":"Arch. Pharm. Res"},{"key":"10.1016\/j.biopha.2026.119184_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nchembio.780","article-title":"Small-molecule\u2013induced DNA damage identifies alternative DNA structures in human genes","volume":"8","author":"Rodriguez","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2026.119184_bib45","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","article-title":"Combenefit: An interactive platform for the analysis and visualization of drug combinations","volume":"32","author":"Di Veroli","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2026.119184_bib46","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41416-023-02394-9","article-title":"Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities","volume":"129","author":"Machado","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119184_bib47","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2026.119184_bib48","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119184_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119184_bib50","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/0008-5472.CAN-21-1223","article-title":"PGC1\u03b1\/\u03b2 Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer","volume":"82","author":"Ghilardi","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2026.119184_bib51","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1158\/2159-8290.CD-20-0844","article-title":"Targeting metabolic plasticity and flexibility dynamics for cancer therapy","volume":"10","author":"Fendt","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2026.119184_bib52","doi-asserted-by":"crossref","DOI":"10.1186\/s40170-022-00286-9","article-title":"Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress","volume":"10","author":"Marx","year":"2022","journal-title":"Cancer Metab."},{"key":"10.1016\/j.biopha.2026.119184_bib53","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1080\/15384101.2017.1387697","article-title":"ATM-mediated mitochondrial damage response triggered by nuclear DNA damage in normal human lung fibroblasts","volume":"16","author":"Shimura","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biopha.2026.119184_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npjamd.2016.22","article-title":"Increased oxidative phosphorylation in response to acute and chronic dna damage","volume":"2","author":"Brace","year":"2016","journal-title":"NPJ Aging Mech. Dis."},{"key":"10.1016\/j.biopha.2026.119184_bib55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1158\/1541-7786.MCR-15-0263","article-title":"Linking cancer metabolism to DNA repair and accelerated senescence","volume":"14","author":"Efimova","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119184_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrm3719","article-title":"Double-strand break repair: 53BP1 comes into focus","volume":"15","author":"Panier","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2026.119184_bib57","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1091\/mbc.E18-10-0650","article-title":"NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival","volume":"30","author":"Murata","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.biopha.2026.119184_bib58","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cell.2019.06.005","article-title":"BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis","volume":"178","author":"Wiel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119184_bib59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia"},{"key":"10.1016\/j.biopha.2026.119184_bib60","doi-asserted-by":"crossref","unstructured":"Wang, X.J., Hayes, J.D., Henderson, C.J. & Roland Wolf, C. Identification of Retinoic Acid as an Inhibitor of Transcription Factor Nrf2 through Activation of Retinoic Acid Receptor Alpha. (2007).","DOI":"10.1073\/pnas.0709483104"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226002179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226002179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:49:31Z","timestamp":1777574971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226002179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":60,"alternative-id":["S0753332226002179"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119184","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119184"}}